Tech Company Financing Transactions
Humane Genomics Funding Round
Humane Genomics, based in New York, raised investment capital from Union Square Ventures and private investors.
Transaction Overview
Company Name
Announced On
2/18/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Union Square Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
180 Varick Street, 6th Floor
New York, NY 10014
USA
New York, NY 10014
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Humane Genomics, we use a first-principle approach to designing oncolytic viral therapies. With a dedicated team of experts and the guidance of world-class advisors, we are on a mission to revolutionize cancer treatment by leveraging the potential of RNA viruses to selectively target and eradicate cancer cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Weijmarshausen
Chief Scientific Officer
Chad Moles
Co-Founder
Andrew Hessel
Browse more venture capital transactions:
Prev: 2/18/2025: Maestro Blockchain venture capital transaction
Next: 2/18/2025: Apaly Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs